# Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

> **NCT02138981** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 436 (estimated)

## Conditions studied

- Resectable Hepatocellular Carcinoma Beyond Milan Criteria

## Interventions

- **PROCEDURE:** Chemoembolization and Response-Dependent Resection
- **PROCEDURE:** Immediate Resection

## Key facts

- **NCT ID:** NCT02138981
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05-01
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 436 (ESTIMATED)
- **Last updated:** 2018-08-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02138981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02138981, "Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02138981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*